Product NDC: | 60505-6080 |
Proprietary Name: | FONDAPARINUX SODIUM |
Non Proprietary Name: | fondaparinux sodium |
Active Ingredient(s): | 7.5 mg/.6mL & nbsp; fondaparinux sodium |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-6080 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021345 |
Marketing Category: | NDA |
Start Marketing Date: | 20110718 |
Package NDC: | 60505-6080-4 |
Package Description: | 10 SYRINGE in 1 CARTON (60505-6080-4) > .6 mL in 1 SYRINGE (60505-6080-0) |
NDC Code | 60505-6080-4 |
Proprietary Name | FONDAPARINUX SODIUM |
Package Description | 10 SYRINGE in 1 CARTON (60505-6080-4) > .6 mL in 1 SYRINGE (60505-6080-0) |
Product NDC | 60505-6080 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fondaparinux sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20110718 |
Marketing Category Name | NDA |
Labeler Name | Apotex Corp. |
Substance Name | FONDAPARINUX SODIUM |
Strength Number | 7.5 |
Strength Unit | mg/.6mL |
Pharmaceutical Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |